ArticleFrontiers in oncology2026
Systemic dysregulation of essential and toxic elements and redox homeostasis in gynecologic malignancies.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endometrial cancer (EC) and ovarian cancer (OC) are among the most prevalent gynecologic malignancies, yet systemic biochemical alterations associated with these diseases remain incompletely characterized. Disturbances in essential and toxic element homeostasis, together with redox imbalance, have been implicated in cancer-related metabolic changes. This study aimed to comprehensively evaluate circulating macro- and trace elements alongside oxidative stress markers in women with EC and OC. Methods: Serum and whole-blood concentrations of sodium (Na), potassium (K), calcium (Ca), phosphorus (P), magnesium (Mg), manganese (Mn), copper (Cu), zinc (Zn), lead (Pb), cadmium (Cd), and iron (Fe) were quantified using inductively coupled plasma optical emission spectrometry (ICP-OES). Systemic redox status was assessed by measuring total antioxidant status (TAS), total oxidant status (TOS), and calculating the oxidative stress index (OSI). Analyses were conducted in women with endometrial cancer stratified by tumor grade, patients with ovarian cancer stratified by treatment strategy, and corresponding control groups. Associations with age, body mass index, menopausal status, and type 2 diabetes were also evaluated. Results: In EC, higher tumor grade was associated with significantly lower circulating levels of Ca, Mg, and Fe, along with increased concentrations of Mn, Cu, Pb, and Cd. Decreasing trends were also observed for K and Zn. A comparable pattern was identified in OC, with the most pronounced alterations in patients requiring surgery followed by chemotherapy. Correlation analyses revealed significant inter-element relationships, particularly involving Mg, Cu, Pb, and Fe. Redox profiling demonstrated a progressive decrease in TAS and corresponding increases in TOS and OSI across tumor grades and clinical subgroups in both malignancies (p < 0.001 for all). Demographic and metabolic factors showed weak and inconsistent associations, with limited explanatory power of regression models. Conclusion: Endometrial and ovarian cancers are associated with distinct yet partially overlapping alterations in systemic elemental composition and redox balance. These changes are stage-associated and may reflect complex, non-specific interactions between disease, host response, and environmental factors, although causality cannot be established. Combined multi-element and redox profiling may provide complementary insights into the systemic biochemical characteristics of gynecologic malignancies; however, further longitudinal and mechanistic studies are required to clarify their clinical relevance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.